Vascular Innovations Webinars

We’re excited to announce Industry-led webinars, hosted by the SVS Foundation, that will convene leading experts to present the latest evidence, case-based discussions and real-world insights shaping vascular access and endovascular care.

Disclaimer: These webinars are the sole content of the Industry Sponsors and do NOT constitute an endorsement by the SVS or the SVS Foundation for any products, therapies, or speaker remarks. The speakers are selected by the Industry Sponsors, and their remarks are their own.

Upcoming Webinars

January 28, 2026 | 6 p.m. CST

From PROMISE to Practice: A New Era for CLTI Care
Presented by Inari - now part of Stryker

Up to 10% of patients with chronic limb-threatening ischemia (CLTI) have exhausted all conventional revascularization options and face a devastating risk of major amputation. Transcatheter arterialization of the deep veins (TADV) with the purpose-built LimFlow System is redefining what’s possible for these no-option patients by restoring blood flow to the foot through the venous system.

Following the encouraging limb-salvage and functional outcomes demonstrated in PROMISE I and the pivotal PROMISE II trial, the PROMISE III study takes the next step—prospectively examining both clinical outcomes and the physiologic maturation of the TADV circuit. In this exclusive webinar, investigators unveil the 6-month primary endpoint results from PROMISE III, showcasing real-world hemodynamic evolution, circuit maturation, and wound-healing patterns that deepen our understanding of how LimFlow works and who benefits most.

Join us for an in-depth discussion on how this innovative therapy is expanding treatment possibilities and reshaping the care paradigm for patients with no-option CLTI.

Learning Objectives:

Understand the unmet need in no-option CLTI and where TADV with LimFlow fits in today’s treatment landscape
Gain practical insight into the TADV procedure, including its physiologic rationale, mechanism of action, and key procedural steps
Evaluate the latest clinical evidence supporting LimFlow therapy, with a focused review of PROMISE III 6-month outcomes and their impact on patient selection, limb salvage, and wound healing

Speakers:

Dr. Jocelyn Beach | Dartmouth Health
Dr. Daniel Clair | Vanderbilt University Medical Center
Dr. Adam Gwozdz | Inari/Stryker

This webinar is free to attend. After clicking "register now," to complete registration, you’ll need to login to your SVS member account. If you’re not an SVS member, simply create a free account to continue.

Past Webinars

Missed the webinars or want a replay? The full recordings are now available to watch on demand on SVS VascuLEARN.

November 12, 2025 - End Stage Kidney Disease & Vascular Access: “Innovation & Improved Fistula Outcomes" Presented by Laminate Medical

Program Highlights

Dr. Keith Ozaki will open with a discussion on the hemodynamic and mechanical factors driving fistula failure, their impact on outcomes, and how VasQ’s unique extravascular support mechanism addresses these challenges.
Dr. Ellen Dillavou will review the extensive clinical evidence behind VasQ, including insights from 15 peer-reviewed publications and her personal clinical experience with the device.
Dr. John Lucas will share his real-world perspective, focusing on basilic vein transpositions and how VasQ integration has improved patient outcomes in his ESKD practice.

What to Expect

30-minute presentation with expert-led discussions
15 minutes of Q&A to address your questions
Interactive participant survey

Discover how VasQ is reshaping fistula care and delivering meaningful results for patients with ESKD.

Speakers: Dr. Keith Ozaki, Dr. Ellen Dillavou, Dr. John Lucas

View the Recording

October 29, 2025 - From Data to Decisions: Optimizing Outcomes in PAD & CLI with Eluvia DES Presented by Boston Scientific

This session will highlight the latest clinical evidence on the Eluvia Drug-Eluting Stent (DES), including insights from the SPORTS RCT, Eluvia Pooled Meta-Analysis, and Eluvia TRUE-PTX data. Faculty experts will discuss how these findings reinforce Eluvia’s advantages over alternative modalities—particularly in treating long, challenging lesions.

Through case-based discussions and interactive dialogue, participants will gain practical strategies for integrating DES therapy into real-world practice and comparing its role to DCB and BMS approaches.

Key topics include:

Clinical data reinforcing Eluvia DES effectiveness
Case insights on long, complex lesions
DES vs. DCB/BMS in decision-making
Real-world outcomes: reduced amputations and re-hospitalizations
Impact on patient quality of life and hospital economics

Don’t miss this opportunity to deepen your knowledge and explore how DES therapy can improve outcomes for patients with PAD and CLI.

Speakers: Dr. Anahita Dua, Massachusetts General Hospital, Dr. Sonya Noor, Buffalo General Medical Center, and Dr. Peter Schneider University of California, San Francisco